Clinical Trials Directory

Trials / Terminated

TerminatedNCT00616954

A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT

An Investigator Initiated, Prospective, Randomized, Controlled Study in Order to Evaluate the Effect of Anti-thymocyte Globulin (Fresenius ATG) on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical Allogeneic Hematopoietic Stem-cell Transplantation

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
3 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study is planned to evaluated whether ATG is needed in haploidentical stem cell transplantation

Conditions

Interventions

TypeNameDescription
DRUGATG-FATG-f

Timeline

Start date
2008-05-01
Primary completion
2010-06-01
Completion
2010-09-01
First posted
2008-02-15
Last updated
2015-04-21

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00616954. Inclusion in this directory is not an endorsement.